The SIRT1 function is decreased in subjects with DM2, and this leads to a reduction in PGC1-α activeness in the liver, an increase in oxidative stress and mitochondrial dysfunction, and liver damage, followed by NAFLD development [137]. This evidence concerns the gene PPARGC1A and metabolic dysfunction-associated steatotic liver disease.